Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

328.55
Delayed Data
As of Oct 23
 -9.55 / -2.82%
Today’s Change
244.28
Today|||52-Week Range
348.84
+25.78%
Year-to-Date

Today’s Trading

Previous close338.10
Today’s open335.25
Day’s range327.83 - 335.51
Volume1,885,197
Average volume (3 months)1,352,001
Market cap$71.5B
Dividend yield--
Data as of 4:00pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+6.49%
Earnings growth (next 5 years)+5.71%
Revenue growth (last year)+9.37%
P/E ratio21.6
Price/Sales6.09
Price/Book6.01

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+1.67+0.80%
GILDGilead Sciences-1.04-1.28%
----
BIVVBioverativ Inc-1.30-2.16%
Data as of 4:00pm ET, 10/23/2017

Financials

Last reporting dateOctober 24, 2017
EPS forecast (this quarter)$5.70
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Senior Vice President-
US Therapeutic Operations
Alisha A. Alaimo
Corporate headquarters
Cambridge, Massachusetts

Forecasts